Etomidate Injection · 1,437 days since initial FDA posting
Brand: ETOMIDATE
FDA lists Etomidate Injection as Active Shortage (Caplin Steriles, Ltd.).
Availability on file: Available
Etomidate Injection: Active Shortage
Available Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Etomidate Injection
- Manufacturer
- Caplin Steriles, Ltd.
- Dosage Form
- Injection
- Presentation
- Etomidate, Injection, 2 mg/mL (NDC 72485-509-10)
- Package NDC
- 72485-509-10
Status & Timeline
- Status
- Active Shortage
- Availability
- Available
- First Reported
- Oct 5, 2022
- Last Updated
- Mar 2, 2026
- Therapeutic Category
- Anesthesia
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Check wholesalers for inventory; Marketed by Armas Pharmaceuticals, Inc. 908-803-2586
Nearby, Other Etomidate Shortage Records
Etomidate Injection
Gland Pharma Limited
Injection
Etomidate Injection
Gland Pharma Limited
Injection
Etomidate Injection
Mylan Institutional, a Viatris Company
Injection
Etomidate Injection
Mylan Institutional, a Viatris Company
Injection
Etomidate Injection
Hospira, Inc., a Pfizer Company
Injection
Etomidate Injection
Hospira, Inc., a Pfizer Company
Injection
FDA reason on file: Check wholesalers for inventory; Marketed by Armas Pharmaceuticals, Inc. General shortage guidance lives on the tracker hub.